Manage New Warnings About Clarithromycin and Cardiovascular Risk
April 2018
Health Canada is investigating a possible link between clarithromycin and an increased risk of CV events or death.
The focus is on patients with coronary artery disease (CAD).
Macrolide antibiotics...clarithromycin, erythromycin, and azithromycin...already have warnings about QT prolongation and torsades.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive